Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016:2016:3801570.
doi: 10.1155/2016/3801570. Epub 2016 Mar 28.

Ocular Complications of Diabetes and Therapeutic Approaches

Affiliations
Review

Ocular Complications of Diabetes and Therapeutic Approaches

Victoria J Vieira-Potter et al. Biomed Res Int. 2016.

Abstract

Diabetes mellitus (DM) is a metabolic disease defined by elevated blood glucose (BG). DM is a global epidemic and the prevalence is anticipated to continue to increase. The ocular complications of DM negatively impact the quality of life and carry an extremely high economic burden. While systemic control of BG can slow the ocular complications they cannot stop them, especially if clinical symptoms are already present. With the advances in biodegradable polymers, implantable ocular devices can slowly release medication to stop, and in some cases reverse, diabetic complications in the eye. In this review we discuss the ocular complications associated with DM, the treatments available with a focus on localized treatments, and what promising treatments are on the horizon.

PubMed Disclaimer

References

    1. Nathan D. M. Diabetes: advances in diagnosis and treatment. Journal of the American Medical Association. 2015;314(10):1052–1062. doi: 10.1001/jama.2015.9536. - DOI - PubMed
    1. Usuelli V., La Rocca E. Novel therapeutic approaches for diabetic nephropathy and retinopathy. Pharmacological Research. 2015;98:39–44. doi: 10.1016/j.phrs.2014.10.003. - DOI - PubMed
    1. Semeraro F., Cancarini A., dell'Omo R., Rezzola S., Romano M. R., Costagliola C. Diabetic retinopathy: vascular and inflammatory disease. Journal of Diabetes Research. 2015;2015:16. doi: 10.1155/2015/582060.582060 - DOI - PMC - PubMed
    1. Gologorsky D., Thanos A., Vavvas D. Therapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathy. Mediators of Inflammation. 2012;2012:10. doi: 10.1155/2012/629452.629452 - DOI - PMC - PubMed
    1. Herse P. R. A review of manifestations of diabetes mellitus in the anterior eye and cornea. American Journal of Optometry and Physiological Optics. 1988;65(3):224–230. doi: 10.1097/00006324-198803000-00013. - DOI - PubMed